“…The other classes of therapeutically available antifungal drugs are not effective alone to treat fungal co-infections in COVID-19 patients managed in the intensive care unit with prolonged immunomodulatory treatments [ 27 , 28 ] and have caused important side effects [ 29 , 30 ]. Triazoles cause hepatotoxicity, drug–drug interactions, QTc prolongation (the heart muscle takes a comparatively longer time to contract and relax than usual), skeletal fluorosis, pseudohyperaldosteronism, adrenal insufficiency, hyponatremia and hypogonadism [ 29 , 30 ]. The most common complications of echinocandins are thrombophlebitis, hepatotoxicity, derangement of serum transaminases, hypotension and fever, but anemia, leukopenia and thrombocytopenia have also been reported [ 31 , 32 , 33 , 34 ].…”